Greenwich LifeSciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
26 Sep 24 | BuyUS$21,945 | Snehal Patel | Individual | 1,500 | US$14.63 | |
12 Aug 24 | BuyUS$11,080 | Jaye Thompson | Individual | 800 | US$13.85 | |
06 Aug 24 | BuyUS$27,620 | Snehal Patel | Individual | 2,000 | US$13.81 | |
05 Aug 24 | BuyUS$72,490 | Snehal Patel | Individual | 5,500 | US$13.18 | |
02 Aug 24 | BuyUS$15,150 | Jaye Thompson | Individual | 1,000 | US$15.15 | |
23 Jul 24 | BuyUS$23,835 | Snehal Patel | Individual | 1,500 | US$15.89 | |
18 Jul 24 | BuyUS$16,000 | Jaye Thompson | Individual | 1,000 | US$16.00 | |
13 Jun 24 | BuyUS$2,499,998 | Snehal Patel | Individual | 174,825 | US$14.30 | |
01 Apr 24 | BuyUS$57,240 | Snehal Patel | Individual | 3,000 | US$19.08 | |
22 Mar 24 | BuyUS$49,950 | Snehal Patel | Individual | 2,500 | US$19.98 | |
20 Mar 24 | BuyUS$26,520 | Snehal Patel | Individual | 1,500 | US$17.68 | |
05 Mar 24 | BuyUS$43,715 | Snehal Patel | Individual | 3,500 | US$12.49 | |
04 Mar 24 | BuyUS$53,423 | Snehal Patel | Individual | 4,100 | US$13.03 | |
16 Feb 24 | BuyUS$120,528 | Snehal Patel | Individual | 10,800 | US$11.16 | |
15 Feb 24 | BuyUS$140,589 | Snehal Patel | Individual | 12,700 | US$11.07 | |
10 Nov 23 | BuyUS$50,838 | Snehal Patel | Individual | 5,000 | US$10.17 | |
03 Nov 23 | BuyUS$31,885 | Snehal Patel | Individual | 3,500 | US$9.11 | |
27 Oct 23 | BuyUS$4,285 | Jaye Thompson | Individual | 500 | US$8.57 | |
26 Oct 23 | BuyUS$19,925 | Snehal Patel | Individual | 2,500 | US$7.97 | |
25 Oct 23 | BuyUS$19,775 | Snehal Patel | Individual | 2,500 | US$7.91 | |
10 Oct 23 | BuyUS$9,070 | Snehal Patel | Individual | 1,000 | US$9.07 |
Insider Trading Volume
Insider Buying: GLSI insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 1,117,250 | 8.5% |
General Public | 4,807,105 | 36.6% |
Individual Insiders | 7,220,298 | 54.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
5,536,102 | US$76.1m | 0.19% | no data | |||
620,327 | US$8.5m | 0% | no data | |||
397,333 | US$5.5m | 0% | no data | |||
313,255 | US$4.3m | 0% | no data | |||
308,909 | US$4.2m | 447% | no data | |||
268,168 | US$3.7m | 20.2% | no data | |||
263,148 | US$3.6m | 1.08% | no data | |||
127,689 | US$1.8m | 119% | no data | |||
90,133 | US$1.2m | 0% | no data | |||
87,000 | US$1.2m | 0% | 1.57% | |||
87,000 | US$1.2m | 0% | 0.01% | |||
68,403 | US$939.9k | 426% | no data | |||
36,900 | US$507.0k | -1.6% | no data | |||
24,320 | US$334.2k | 14.6% | no data | |||
18,454 | US$253.6k | 0% | no data | |||
16,650 | US$228.8k | 46.5% | no data | |||
15,295 | US$210.2k | 0% | no data | |||
7,053 | US$96.9k | 13.2% | no data | |||
6,799 | US$93.4k | 0% | no data | |||
6,328 | US$86.9k | 12.3% | no data | |||
6,000 | US$82.4k | 0% | no data | |||
4,800 | US$66.0k | 0% | no data | |||
3,428 | US$47.1k | 29.2% | no data | |||
3,212 | US$44.1k | 0% | no data | |||
2,544 | US$34.9k | 0% | no data |